- Preamble [SYSTEM]
- Fund & Investor Interest
- Street Moves
- Solebury Trout Updates
- Market Commentary
- IPO News
- Expert Interactions
- Banker Comments & Notes
- Conference Snippet
- Industry Snippets
- Social Media
- Solebury Trout Talks
- SoftBank Plans to Invest Billions in Biotech Stocks
- In search of 'household healthcare brands of the future,' Foresite Capital raises $969M to satiate a tech-heavy appetite
- OrbiMed, biopharma's biggest investor, closes $3.5B in three new private funds
- Broadridge 2021 EDGAR Filing Calendar
- Life Sci VC - The Record-Breaking Biotech Funding Tsunami Of 1H2020
- SEC Proposes Amendments to Update Form 13F for Institutional Investment Managers; Amend Reporting Threshold to Reflect Today’s Equities Markets
- Reuters - Hedge fund Hoplite Capital plans to shut down - letter
- Nasdaq - Capital Markets Trends: Biotech
- Pitchbook - 18 charts to illustrate US VC in 2018
- New HBM Report - Analysis of FDA New Drug Approvals 2018 (and Multi-Year Trends)
- WSJ - Biotech Startup Moderna Drops an Underwriter Ahead of IPO
- Scott Davis & Carter Copeland At Melius - A Year into MiFID II
- Solebury Trout BD takeaways from Boston BD Roundtable and Hamptons BD Panel